Skip to main content
logo
Elixinol Wellness Limited (ASX:EXL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0070
0.00 (0.00%)
Mar 25, 2026, 3:56 PM AEST

Elixinol Wellness Revenue

In the year 2025, Elixinol Wellness had annual revenue of 15.50M AUD with 3.64% growth. Elixinol Wellness had revenue of 7.84M in the half year ending December 31, 2025, with 62.75% growth.

Revenue
15.50M
Revenue Growth
+3.64%
P/S Ratio
0.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.50M544.00K3.64%
Dec 31, 202414.96M6.69M80.87%
Dec 31, 20238.27M1.21M17.21%
Dec 31, 20227.06M-2.28M-24.45%
Dec 31, 20219.34M-5.67M-37.79%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vitura Health129.24M
Little Green Pharma38.49M
ECS Botanics Holdings20.97M
IDT Australia19.00M
Peak Processing14.59M
Cann Group11.31M
Epsilon Healthcare9.39M
Percheron Therapeutics1.74M
Revenue Rankings

Elixinol Wellness News

More News